Close

Pre-Open Stock Movers 01/06: (CNAT) (CCXI) (MBLY) Higher; (CMG) (VRX) (AAPL) Lower (more...)

January 6, 2016 9:28 AM EST Send to a Friend
Conatus Pharmaceuticals (NASDAQ: CNAT) 24.6% HIGHER; three-month, double-blind, placebo-controlled stage of the company’s multicenter Phase 2 Liver Cirrhosis clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login